Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis

by Abu-Sbeih, Hamzah, Ali, Faisal S., Luo, Wenyi, Qiao, Wei, Raju, Gottumukkala S., Wang, Yinghong
Published in J Immunother Cancer (2018)

Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment

by Abu-Sbeih, Hamzah, Tran, Cynthia Nguyen, Ge, Phillip S., Bhutani, Manoop S., Alasadi, Mazen, Naing, Aung, Jazaeri, Amir A., Wang, Yinghong
Published in J Immunother Cancer (2019)

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

by Abu-Sbeih, Hamzah, Ali, Faisal S., Alsaadi, Dana, Jennings, Joseph, Luo, Wenyi, Gong, Zimu, Richards, David M., Charabaty, Aline, Wang, Yinghong
Published in J Immunother Cancer (2018)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

by Abu-Sbeih, Hamzah, Tang, Tenglong, Lu, Yang, Thirumurthi, Selvi, Altan, Mehmet, Jazaeri, Amir A., Dadu, Ramona, Coronel, Emmanuel, Wang, Yinghong
Published in J Immunother Cancer (2019)

Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia

by Abu-Sbeih, Hamzah, Ali, Faisal S., Qiao, Wei, Lum, Phillip, Shafi, Mehnaz A., Bresalier, Robert S., Hawk, Ernest, Raju, Gottumukkala S., Wang, Yinghong
Published in J Cancer (2020)

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

by Abu-Sbeih, Hamzah, Herrera, Lauren Nicholas, Tang, Tenglong, Altan, Mehmet, Chaftari, Anne-Marie, Okhuysen, Pablo C., Jenq, Robert R., Wang, Yinghong
Published in J Immunother Cancer (2019)

Patients with breast cancer may be at higher risk of colorectal neoplasia

by Abu-Sbeih, Hamzah, Ali, Faisal S., Ge, Phillip S., Barcenas, Carlos H., Lum, Phillip, Qiao, Wei, Bresalier, Robert S., Bhutani, Manoop S., Raju, Gottumukkala S., Wang, Yinghong
Published in Ann Gastroenterol (2019)

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

by Abu-Sbeih, Hamzah, Herrera, Lauren Nicholas, Tang, Tenglong, Altan, Mehmet, Chaftari, Anne-Maria P., Okhuysen, Pablo C., Jenq, Robert R., Wang, Yinghong
Published in J Immunother Cancer (2019)

Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy

by Abu-Sbeih, Hamzah, Mallepally, Niharika, Goldstein, Ryan, Chen, Ellie, Tang, Tenglong, Dike, Uzoamaka K., Al-Asadi, Mazen, Westin, Shannon, Halperin, Daniel, Wang, Yinghong
Published in J Cancer (2020)

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

by Wang, Yinghong, Abu-Sbeih, Hamzah, Mao, Emily, Ali, Noman, Ali, Faisal Shaukat, Qiao, Wei, Lum, Phillip, Raju, Gottumukkala, Shuttlesworth, Gladis, Stroehlein, John, Diab, Adi
Published in J Immunother Cancer (2018)

Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?

by Choi, Kati, Abu-Sbeih, Hamzah, Samdani, Rashmi, Nogueras Gonzalez, Graciela, Raju, Gottumukkala Subba, Richards, David M, Gao, Jianjun, Subudhi, Sumit, Stroehlein, John, Wang, Yinghong
Published in Inflamm Bowel Dis (2019)

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

by Abu-Sbeih, Hamzah, Ali, Faisal S., Wang, Xuemei, Mallepally, Niharika, Chen, Ellie, Altan, Mehmet, Bresalier, Robert S., Charabaty, Aline, Dadu, Ramona, Jazaeri, Amir, Lashner, Bret, Wang, Yinghong
Published in J Immunother Cancer (2019)

Clinical characteristics of colitis induced by taxane-based chemotherapy

by Chen, Ellie, Abu-Sbeih, Hamzah, Thirumurthi, Selvi, Mallepally, Niharika, Khurana, Shruti, Wei, Dongguang, Altan, Mehmet, Morris, Van K., Tan, Dongfeng, Barcenas, Carlos H., Wang, Yinghong
Published in Ann Gastroenterol (2020)

Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort

by Pomenti, Sydney, Gandle, Cassandra, Abu Sbeih, Hamzah, Phipps, Meaghan, Livanos, Alexandra, Guo, Averill, Yeh, Jonathan, Burney, Heather, Liu, Hao, Dakhoul, Lara, Kettler, Carla, Gawrieh, Samer, deLemos, Andrew, Scanga, Andrew, Chalasani, Naga, Miller, Ethan, Wattacheril, Julia
Published in Hepatol Commun (2020)

Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate

by Raju, Gottumukkala S., Lum, Phillip, Abu-Sbeih, Hamzah, Ross, William A., Thirumurthi, Selvi, Miller, Ethan, Lynch, Patrick, Lee, Jeffrey, Bhutani, Manoop S., Shafi, Mehnaz, Weston, Brian, Rashid, Asif, Wang, Yinghong, Chang, George J., Carlson, Richard, Hagan, Katherine, Davila, Marta, Stroehlein, John
Published in Endosc Int Open (2020)

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

by Abu-Sbeih, Hamzah, Ali, Faisal S., Naqash, Abdul Rafeh, Owen, Dwight H., Patel, Sandipkumar, Otterson, Gregory A., Kendra, Kari, Ricciuti, Biagio, Chiari, Rita, De Giglio, Andrea, Sleiman, Joseph, Funchain, Pauline, Wills, Beatriz, Zhang, Jiajia, Naidoo, Jarushka, Philpott, Jessica, Gao, Jianjun, Subudhi, Sumit K., Wang, Yinghong
Published in J Clin Oncol (2019)

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

by Johnson, Daniel H, Zobniw, Chrystia M, Trinh, Van A, Ma, Junsheng, Bassett, Roland L, Abdel-Wahab, Noha, Anderson, Jaime, Davis, Jennifer E, Joseph, Jocelyn, Uemura, Marc, Noman, Ali, Abu-Sbeih, Hamzah, Yee, Cassian, Amaria, Rodabe, Patel, Sapna, Tawbi, Hussein, Glitza, Isabella C, Davies, Michael A, Wong, Michael K, Woodman, Scott, Hwu, Wen-Jen, Hwu, Patrick, Wang, Yinghong, Diab, Adi
Published in J Immunother Cancer (2018)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

by Brahmer, Julie R, Abu-Sbeih, Hamzah, Ascierto, Paolo Antonio, Brufsky, Jill, Cappelli, Laura C, Cortazar, Frank B, Gerber, David E, Hamad, Lamya, Hansen, Eric, Johnson, Douglas B, Lacouture, Mario E, Masters, Gregory A, Naidoo, Jarushka, Nanni, Michele, Perales, Miguel-Angel, Puzanov, Igor, Santomasso, Bianca D, Shanbhag, Satish P, Sharma, Rajeev, Skondra, Dimitra, Sosman, Jeffrey A, Turner, Michelle, Ernstoff, Marc S
Published in J Immunother Cancer (2021)

Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

by Johnson, Daniel H., Zobniw, Chrystia M., Trinh, Van A., Ma, Junsheng, Bassett Jr, Roland L., Abdel-Wahab, Noha, Anderson, Jaime, Davis, Jennifer E., Joseph, Jocelyn, Uemura, Marc, Noman, Ali, Abu-Sbeih, Hamzah, Yee, Cassian, Amaria, Rodabe, Patel, Sapna, Tawbi, Hussein, Glitza, Isabella C., Davies, Michael A., Wong, Michael K., Woodman, Scott, Hwu, Wen-Jen, Hwu, Patrick, Wang, Yinghong, Diab, Adi
Published in J Immunother Cancer (2019)

Fecal Microbiota Transplantation for refractory immune checkpoint inhibitor-associated colitis

by Wang, Yinghong, Wiesnoski, Diana H., Helmink, Beth A., Gopalakrishnan, Vancheswaran, Choi, Kati, DuPont, Hebert L., Jiang, Zhi-Dong, Abu-Sbeih, Hamzah, Sanchez, Christopher A., Chang, Chia-Chi, Parra, Edwin R., Francisco-Cruz, Alejandro, Raju, Gottumukkala S., Stroehlein, John R., Campbell, Matthew T., Gao, Jianjun, Subudhi, Sumit K., Maru, Dipen M., Blando, Jorge M., Lazar, Alexander, Allison, James P., Sharma, Padmanee, Tetzlaff, Michael T., Wargo, Jennifer A., Jenq, Robert R.
Published in Nat Med (2018)